Sosei Heptares
Sosei Heptares is a biopharmaceutical company that develops and commercializes medicines for the treatment of CNS and inflammation diseases.
Business Model:
Revenue: $71.7M
Employees: 51-200
Industries / Tags:
Detailed Sosei Heptares Information
Sosei Heptares was acquired by
Sosei Group.
The acquisition happend on 2015-02-22.
Details of the transaction were not public
Acquirer
Geographic Data
Address: PMO Hanzomon 11F
City: Tokyo
State: tōkyō prefecture
Zip: 102-0083
Country: JP
Financial Info
Stage:
series unknown
Raised Last:
$5M
Raised Total:$62M
Social
Metrics
2,241,052Website Global Rank
8,554Website Monthly Traffic
Twitter Followers
Description
Sosei Heptares is a biopharmaceutical company that develops and commercializes medicines for the treatment of CNS and inflammation diseases.
Contact Phone:
Contact Email:
Sosei Heptares went public on the Tokyo Stock Exchange
Listed Exchange:
Tokyo Stock Exchange
Ticker Symbol:
4565
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2013 | Series B | $0 |
Takeda Ventures Clarus Ventures Stanley Family Foundation Clarus Ventures Stanley Family Foundation Takeda Ventures Clarus Ventures Stanley Family Foundation Clarus Ventures Stanley Family Foundation |
8/2007 | Seed Round | 1 | - |
MVM Life Science Partners MVM Life Science Partners |
9/2015 | Grant | $5.5M | 5/2017 | Venture Round | 1 | $5M |
Teva Pharmaceutical Industries Teva Pharmaceutical Industries |
7/2020 | Equity | $200M | 2/2009 | Series A | 3 | $30M |
Clarus Ventures MVM Life Science Partners Novartis Venture Fund Clarus Ventures MVM Life Science Partners Novartis Venture Fund |
12/2021 | Grant | - | 12/2021 | Grant | - |
Wellcome Wellcome |
6/2013 | Series B | 3 | $21M |
Takeda Ventures Clarus Ventures Stanley Family Foundation Clarus Ventures Stanley Family Foundation Takeda Ventures Clarus Ventures Stanley Family Foundation Clarus Ventures Stanley Family Foundation |
8/2007 | Seed Round | 1 | - |
MVM Life Science Partners MVM Life Science Partners |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2016 | G7 Therapeutics | |
| 12/2014 | JITSUBO |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
